KLOW 80mg

KLOW 80mg GHK-Cu 50mg BPC-157 10mg TB-500 10mg KPV 10mg

KLOW Blend – Multi‑Pathway Recovery Peptide Matrix
(For Research Use Only)
KLOW Blend is a multi‑target peptide formulation containing GHK‑Cu (50 mg), BPC‑157 (10 mg), TB‑500 (10 mg), and KPV (10 mg), designed for advanced exploration of tissue‑integrity, inflammatory, and repair‑related mechanisms in preclinical settings. The combination allows researchers to study how regenerative, angiogenic, and anti‑inflammatory pathways interact under a single experimental condition.

Key Research Components
• GHK‑Cu 50 mg – Tricarboxylic copper‑binding peptide often investigated in models of skin repair, collagen synthesis, and extracellular‑matrix remodeling.
• BPC‑157 10 mg – Gastric‑derived pentadecapeptide widely studied for its impact on tendon, ligament, and gastrointestinal tissue models, with an emphasis on angiogenesis and structural integrity.
• TB‑500 10 mg – Thymosin beta‑4 fragment associated with actin dynamics, cell migration, and soft‑tissue repair paradigms in experimental systems.
• KPV 10 mg – Alpha‑MSH–derived tripeptide researched for anti‑inflammatory and barrier‑function–related effects in mucosal and dermal models.

Quality and Handling
• Each peptide is supplied in research‑grade quality and combined under controlled conditions to support reproducible study design.
• Formulated for convenient aliquoting, standardized dosing strategies, and integration into existing peptide research panels.
• Recommended for use in well‑characterized models with clearly defined endpoints (e.g., histology, gene expression, functional recovery metrics).

Research‑Only Compliance Notice
KLOW Blend is for research use only and is not approved for human or veterinary use. It is not a drug, food, cosmetic, or dietary supplement and must not be marketed, labeled, or represented as such. This material is intended solely for qualified professionals working in appropriate laboratory environments and in accordance with all applicable laws and regulations. No medical, performance, or therapeutic claims are made or implied; any discussion of biological activity refers exclusively to preclinical and mechanistic work in experimental models.